Loading organizations...
Loading organizations...
Molecular Products designs and manufactures life-critical devices for breathable gas treatment. Offerings include activated carbon filtration media for respirators and carbon dioxide absorbers for anesthesia. These technologies ensure breathable atmospheres in demanding environments, serving medical, defense, diving, and industrial safety markets.
The company originated as Medical Practitioners United Drug Co in 1924, supplying calcium chloride to pharmacies in East London. Bill McKernan acquired it in 1973. Renamed Molecular Products Group in 1988, this evolution was spurred by the need for industrial diving and safety products during North Sea exploration.
Molecular Products' solutions are deployed across medical, defense, diving, and safety sectors where finite air supply is critical. Its vision focuses on sustaining human life and safe environments by continuously advancing innovative technologies and expanding its international footprint.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| May 1, 2022 | VirgoCX | $8.0M Series A | Andrew Tang | Draper Associates, How Link Investment, OKX Ventures, Sora Ventures |